Phosphorylation status and prognostic impacts of RSK2, PDPK1, and AKT in malignant lymphoma. Onishi A, Miyagawa-Hayashino A, Okamoto H, Fujino T, et al. Leuk Lymphoma 2025 Mar 25:1-12. doi: 10.1080/10428194.2025.2482891.

Read + Share

Amedeo Smart

Independent Medical Education

Onishi A, Miyagawa-Hayashino A, Okamoto H, Fujino T, et al. Phosphorylation status and prognostic impacts of RSK2, PDPK1, and AKT in malignant lymphoma. Leuk Lymphoma 2025 Mar 25:1-12. doi: 10.1080/10428194.2025.2482891.
PMID: 40131306